. Author manuscript; available in PMC: 2020 Dec 6.

Published in final edited form as: J Neuroimmune Pharmacol. 2020 May 22;15(4):765–779. doi: 10.1007/s11481-020-09921-y

Table 5.

Research Priorities

• Determine the long-term neurocognitive consequences of chronic cannabis use

• Identify the role of mediating mechanisms for the additive or interactive effects of HIV and cannabis use (e.g., neuroinflammation)

• Examine the potential moderating role of “time of initiation of use” - before or after HIV diagnosis?

• Investigate the differential or combined effects of CBD versus THC (and other cannabinoids)

• Establish evidence related to the medicinal benefits of cannabis or cannabinoids for HIV disease